GeneVida was founded in spring 2013 as subsidiary of Zhejiang Hisoar Pharmaceutical Co. Ltd. (Hisoar). The objective of GeneVida is to offer high quality generic pharmaceutical on European markets.

Zhejiang Hisoar Pharmaceutical Co., Ltd. located in Taizhou, Zhejiang, is a stock listed company engaged in the production and sale of fine chemicals and pharmaceutical active ingredients. It is one of Top100 Chinese pharmaceutical industry enterprises in terms of innovation and in sales revenues (about US$ 250 million). Amongst the most important products range active substances produced by fermentation, such as clindamycin. Exported products account for 70% of Hisoar’s revenues. In 2008, a strategic partnership between Boehringer Ingelheim and Hisoar was founded.